Eurofins Scientific
Search results
Jun 10, 2024 · Ipsen is a mid-sized global biopharmaceutical company that develops and commercializes medicines in oncology, rare disease and neuroscience. Learn about its strategy, pipeline, partnerships, financial results, sustainability and careers.
- Français FR
Ipsen s’investit dans la sauvegarde et la préservation de...
- Investors
Discover Ipsen in two pages; our products and key figures,...
- Financial Results
Building on solid FY 2023 results, Ipsen anticipates four...
- Financial Calendar
Find information on Ipsen’s financial calendar, including...
- Pipeline
Ipsen has been around for around 100 years and plans to be...
- Français FR
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on transformative medicines in three therapeutic areas: oncology, rare disease and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
Ipsen is a mid-size pharmaceutical company that develops and markets products in oncology, rare disease and neuroscience. Learn about its history, strategy, ESG commitment, global presence and Fondation Ipsen.
Ipsen designs and manufactures industrial vacuum furnaces, atmosphere furnaces, and controls for thermal processing markets.
Ipsen is a global biopharmaceutical company that innovates for healthy lives and a better tomorrow. Explore Ipsen careers in various fields and join a culture of collaboration and excellence.
Ipsen is a public company that develops and markets medicines for oncology, rare disease and neuroscience. It has offices and employees in more than 40 countries and partners with external innovators.
Ipsen is a mid-size biopharmaceutical company with over 5,000 employees and products registered in 88 countries. It aims to innovate for patients with high unmet medical need and has a history of nearly 100 years in the industry.
